CoChat

A Quantitative Proteomics Analysis of Subcellular Proteome Localization and Changes Induced by DNA Damage

Open access
Boisvert, François-Michel, Lam, Yun Wah, Lamont, Douglas, Lamond, Angus I. · 2010 · Molecular & Cellular Proteomics

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

A major challenge in cell biology is to identify the subcellular distribution of proteins within cells and to characterize how protein localization changes under different cell growth conditions and in response to stress and other external signals. Protein localization is usually determined either by microscopy or by using cell fractionation combined with protein blotting techniques. Both these approaches are intrinsically low throughput and limited to the analysis of known components. Here we use mass spectrometry-based proteomics to provide an unbiased, quantitative, and high throughput approach for measuring the subcellular distribution of the proteome, termed "spatial proteomics." The spatial proteomics method analyzes a whole cell extract created by recombining differentially labeled subcellular fractions derived from cells in which proteins have been mass-labeled with heavy isotopes. This was used here to measure the relative distribution between cytoplasm, nucleus, and nucleolus of over 2,000 proteins in HCT116 cells. The data show that, at steady state, the proteome is predominantly partitioned into specific subcellular locations with only a minor subset of proteins equally distributed between two or more compartments. Spatial proteomics also facilitates a proteome-wide comparison of changes in protein localization in response to a wide range of physiological and experimental perturbations, shown here by characterizing dynamic changes in protein localization elicited during the cellular response to DNA damage following treatment of HCT116 cells with etoposide. DNA damage was found to cause dissociation of the proteasome from inhibitory proteins and assembly chaperones in the cytoplasm and relocation to associate with proteasome activators in the nucleus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m900429-mcp200

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. A, human colon carcinoma HCT116 cells were grown in DMEM containing either the normal light isotopes of carbon and nitrogen (i.e. 12C14N) (light), l-[13C6,14N4]arginine and l-[2H4]lysine (medium), or l-[13C6,15N4]arginine and l-[13C6,15N2]lysine (heavy). Separate cytoplasmic, nuclear, and nucleolar fractions were isolated from each labeled cell population. B, equal amounts of total protein from each fraction were then recombined to recreate a whole cell extract but with Cyto, Nuc, and No arising from cells with different isotope labels. The recombined whole cell extract mixture was solubilized with loading buffer; proteins were separated using SDS-PAGE; and the resulting gel was cut into eight equal pieces, trypsin-digested, and analyzed by LC-MS/MS using an LTQ Orbitrap. Triplicate fractions and LC-MS/MS resulted in a proteome of 2,536 proteins.
Fig. 1. A, human colon carcinoma HCT116 cells were grown in DMEM containing either the normal light isotopes of carbon and nitrogen (i.e. 12C14N) (light), l-[13C6,14N4]arginine and l-[2H4]lysine (medium), or l-[13C6,15N4]arginine and l-[13C6,15N2]lysine (heavy). Separate cytoplasmic, nuclear, and nucleolar fractions were isolated from each labeled cell population. B, equal amounts of total protein from each fraction were then recombined to recreate a whole cell extract but with Cyto, Nuc, and No arising from cells with different isotope labels. The recombined whole cell extract mixture was solubilized with loading buffer; proteins were separated using SDS-PAGE; and the resulting gel was cut into eight equal pieces, trypsin-digested, and analyzed by LC-MS/MS using an LTQ Orbitrap. Triplicate fractions and LC-MS/MS resulted in a proteome of 2,536 proteins.CC BY-NC · PubMed Central
Fig. 2. Equal amounts (5 μg) of extract from total cell lysate (TCL) or from cytoplasmic, nuclear, or nucleolar fractions of HCT116 cells were separated by SDS-PAGE and transferred to nitrocellulose, and Western blotting was performed using antibodies recognizing α-tubulin (A), lamin B (B), or RPA194 (C). Alternatively, HCT116 cells were grown on coverslips, fixed, and processed for fluorescence microscopy using the same antibodies used for Western blotting. An example of a spectrum from each of the proteins derived from the spatial proteomics mass spectrometry run is also shown. The table shows the ratios of enrichment of Nuc/Cyto, No/Cyto, and No/Nuc.
Fig. 2. Equal amounts (5 μg) of extract from total cell lysate (TCL) or from cytoplasmic, nuclear, or nucleolar fractions of HCT116 cells were separated by SDS-PAGE and transferred to nitrocellulose, and Western blotting was performed using antibodies recognizing α-tubulin (A), lamin B (B), or RPA194 (C). Alternatively, HCT116 cells were grown on coverslips, fixed, and processed for fluorescence microscopy using the same antibodies used for Western blotting. An example of a spectrum from each of the proteins derived from the spatial proteomics mass spectrometry run is also shown. The table shows the ratios of enrichment of Nuc/Cyto, No/Cyto, and No/Nuc.CC BY-NC · PubMed Central
Fig. 3. A, hierarchical clustering was performed using the localization ratios (a) No/Nuc, (b) No/Cyto, and (c) Nuc/Cyto and represented as a tree. In each case, high ratios are shown in red, low ratios are in green, and a 1:1 ratio is in black. B, visualization of the spatial proteomics data by graphical representation, plotting the log base 2 nuclear/cytoplasmic ratio on the x axis and log base 2 nucleolar/cytoplasmic ratio on the y axis. C, the Sm proteins associated with the small nuclear RNP subunits of spliceosomes (blue), proteins associated with small nucleolar RNPs (snoRNPs; red), and protein subunits of the 26 S proteasome cluster (green) are shown as examples. PEP, posterior error probability.
Fig. 3. A, hierarchical clustering was performed using the localization ratios (a) No/Nuc, (b) No/Cyto, and (c) Nuc/Cyto and represented as a tree. In each case, high ratios are shown in red, low ratios are in green, and a 1:1 ratio is in black. B, visualization of the spatial proteomics data by graphical representation, plotting the log base 2 nuclear/cytoplasmic ratio on the x axis and log base 2 nucleolar/cytoplasmic ratio on the y axis. C, the Sm proteins associated with the small nuclear RNP subunits of spliceosomes (blue), proteins associated with small nucleolar RNPs (snoRNPs; red), and protein subunits of the 26 S proteasome cluster (green) are shown as examples. PEP, posterior error probability.CC BY-NC · PubMed Central
Fig. 4. Changes in protein localization were determined using spatial proteomics by comparing cells that were either MT or treated with 50 mm etoposide for 1 h. A, the entire experiment was repeated three times, and a whole cell extract recombining cytoplasmic, nuclear, and nucleolar fractions with separate light, medium, and heavy isotopes was prepared independently for the MT and Eto 1, 2, and 3 samples. Experiment 1 was run twice on the mass spectrometer (MT1a and -b and Eto1a and -b). B, HCT116 cells were either MT (lanes 1–4) or else exposed to a final concentration of 50 μm Eto (lanes 5–8) for 1 h, which caused the expected nuclear increase in phosphorylation of H2AX. C, scatter plot showing the comparison of the cytoplasmic versus nuclear distribution of MT1 and MT2. D, scatter plot showing the comparison of the cytoplasm versus nuclear distribution of MT1 versus Eto1. E, scatter plot showing the cytoplasm versus nuclear (x axis) and the cytoplasm versus nucleolar (y axis) distribution of proteins following mock treatment. F, scatter plot showing the cytoplasm versus nuclear (x axis) and the cytoplasm versus nucleolar (y axis) distribution of proteins following etoposide treatment. Cytoplasmic proteins are shown in blue, nuclear proteins are shown in green, and nucleolar proteins are shown in red. TCL, total cell lysate.
Fig. 4. Changes in protein localization were determined using spatial proteomics by comparing cells that were either MT or treated with 50 mm etoposide for 1 h. A, the entire experiment was repeated three times, and a whole cell extract recombining cytoplasmic, nuclear, and nucleolar fractions with separate light, medium, and heavy isotopes was prepared independently for the MT and Eto 1, 2, and 3 samples. Experiment 1 was run twice on the mass spectrometer (MT1a and -b and Eto1a and -b). B, HCT116 cells were either MT (lanes 1–4) or else exposed to a final concentration of 50 μm Eto (lanes 5–8) for 1 h, which caused the expected nuclear increase in phosphorylation of H2AX. C, scatter plot showing the comparison of the cytoplasmic versus nuclear distribution of MT1 and MT2. D, scatter plot showing the comparison of the cytoplasm versus nuclear distribution of MT1 versus Eto1. E, scatter plot showing the cytoplasm versus nuclear (x axis) and the cytoplasm versus nucleolar (y axis) distribution of proteins following mock treatment. F, scatter plot showing the cytoplasm versus nuclear (x axis) and the cytoplasm versus nucleolar (y axis) distribution of proteins following etoposide treatment. Cytoplasmic proteins are shown in blue, nuclear proteins are shown in green, and nucleolar proteins are shown in red. TCL, total cell lysate.CC BY-NC · PubMed Central
Fig. 5. A, proteins with the gene ontology annotation proteolysis are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). B, proteins with the gene ontology annotation ribosomal are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). C, proteins PSMA1–7 and PSMB1–7 forming the 20 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). D, proteins PSME1–3 forming the 11 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). E, proteins PSMC1–6 and PSMD1–2 forming the base of the 19 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). F, proteins PSMD3–14 forming the lid of the 19 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). G, proteins showing the highest relocalization to the nucleus after etoposide and proteins showing no relocalization to the nucleus are displayed with the log base 2 ratio of their enrichment in each compartment.
Fig. 5. A, proteins with the gene ontology annotation proteolysis are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). B, proteins with the gene ontology annotation ribosomal are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). C, proteins PSMA1–7 and PSMB1–7 forming the 20 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). D, proteins PSME1–3 forming the 11 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). E, proteins PSMC1–6 and PSMD1–2 forming the base of the 19 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). F, proteins PSMD3–14 forming the lid of the 19 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). G, proteins showing the highest relocalization to the nucleus after etoposide and proteins showing no relocalization to the nucleus are displayed with the log base 2 ratio of their enrichment in each compartment.CC BY-NC · PubMed Central
Fig. 6. A, protein complexes that showed a specific change in localization after etoposide treatment were clustered according to the log base 2 ratios and displayed as a heat map where green represents negative values and red represents positive values. B, a cluster containing the replication protein A complex proteins and the MCM complex proteins MCM2–7 all showed a similar specific change in their spatial proteome. C, the proteins displayed in B are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (green) or etoposide- treated (red). D, Western blotting of the total cell lysate (TCL), Cyto, Nuc, and No fractions of either mock-treated (lanes 1–4) or etoposide-treated (lanes 5–8) cells with an MCM5 antibody. E and F, spectra for peptides from MCM5 derived from either mock-treated cells (E) or etoposide-treated cells (F) are displayed.
Fig. 6. A, protein complexes that showed a specific change in localization after etoposide treatment were clustered according to the log base 2 ratios and displayed as a heat map where green represents negative values and red represents positive values. B, a cluster containing the replication protein A complex proteins and the MCM complex proteins MCM2–7 all showed a similar specific change in their spatial proteome. C, the proteins displayed in B are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (green) or etoposide- treated (red). D, Western blotting of the total cell lysate (TCL), Cyto, Nuc, and No fractions of either mock-treated (lanes 1–4) or etoposide-treated (lanes 5–8) cells with an MCM5 antibody. E and F, spectra for peptides from MCM5 derived from either mock-treated cells (E) or etoposide-treated cells (F) are displayed.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 193

Metadata

Authors
Boisvert, F.-M., Lam, Y. W., Lamont, D., & Lamond, A. I.
Affiliations
  • University of Dundee (GB)
  • City University of Hong Kong (HK)
Corresponding author
Lamond, Angus I.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2010-03
Volume
9
Issue
3
Pages
457-470
ISSN
1535-9476 (ISSN-L)
OpenAlex
W2142583027
Cited by
185
References
36
Citations by year
2026: 1 · 2025: 2 · 2024: 8 · 2023: 2 · 2022: 13 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 11 · 2017: 14 · 2016: 16 · 2015: 9 · 2014: 15 · 2013: 19 · 2012: 21
FWCI
8.45
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular & Cellular Proteomics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • CityU Scholars (submittedVersion, cc-by)
Funders
Wellcome Trust (073980, 073980/Z/03/Z)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords
spatial proteomics, DNA damage response, etoposide, proteasome, nucleolus, cytoplasm, nucleus, HCT116 cells, heavy isotope labeling, subcellular protein distribution
MeSH terms
Antineoplastic Agents, Phytogenic, Cell Extracts, Cell Nucleolus, Cytoplasm, DNA, DNA Damage, Etoposide, Humans, Isotope Labeling, Subcellular Fractions, Molecular Chaperones, Proteome, Proteomics, HCT116 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Quantitative Proteomics Analysis of Subcellular Proteome Localization and Changes Induced by DNA Damage. https://app.cochat.ai/papers/10.1074/mcp.m900429-mcp200
The paper
Boisvert, F.-M., Lam, Y. W., Lamont, D., & Lamond, A. I. (2010). A Quantitative Proteomics Analysis of Subcellular Proteome Localization and Changes Induced by DNA Damage. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.m900429-mcp200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.